Dr. Maria Kristina C. Dorotan, MD

Dr. Dorotan practices at Yale Medicine in New Haven, Connecticut.

Dr. Dorotan's NPI, 1982125282, was assigned on June 28, 2017. Dr. Dorotan graduated from University of Santo Tomas in 2013. Dr. Dorotan holds Connecticut license 72554.

Dr. Dorotan's primary practice is Yale Medicine, at 50 Division St, New Haven, CT 06511 in South Central Ct County. The practice phone is (203) 785-2140.

Dr. Dorotan's primary practice is Yale Medicine in New Haven, Connecticut. Dr. Dorotan is also affiliated with Yale New Haven Hospital. The medical group on file is Yale Health. Dmand AI also links Dr. Dorotan to 4 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dorotan practices, 5 sites in all. Vendor and product names are available with a free account.

Epilepsy is Dr. Dorotan's primary specialty in the NPI Registry, under taxonomy code 2084E0001X. Dr. Dorotan is board certified in epilepsy by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Dorotan's licenses on file in 3 states: Connecticut, Massachusetts and Pennsylvania.

Dmand AI lists epilepsy and seizures among the conditions Dr. Dorotan treats.

CMS data shows 430 Medicare services from Dr. Dorotan across 12 procedure codes in 2024, for 307 Medicare patients. Medicare paid $45,033 for them.

CMS counts 307 Medicare patients who saw Dr. Dorotan in 2024. The largest group is 65 to 74, with 89 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 49% are also on Medicaid. Their average risk score is 2.41, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dorotan's median patient age at 59, with 57% women.

In 2024, Dr. Dorotan wrote 1,191 Medicare Part D claims for 189 patients. 76% of them were for generic drugs. CMS names the drug for 1,105 of them, across 24 drugs with 11 or more claims each, at $302,831 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Dorotan for performance year 2024, reported as part of a group. Dr. Dorotan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dorotan as offering telehealth.

Dmand AI links 7 papers to Dr. Dorotan, published from 2023 to 2025. 2024 was the busiest year, with 3. The most frequent topics are Epilepsy, Anticonvulsants and Seizures. Dr. Dorotan has published most often in Epilepsia. Dr. Dorotan's most frequent co-authors are Steven D. Tobochnik, MD, Wadih Baajour and Samuel Waller Terman, MD.

CMS Open Payments shows 7 general payments to Dr. Dorotan from 3 drug and device companies in 2025. Travel and lodging make up the largest share, 89% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $1,019.

Dr. Dorotan graduated from University of Santo Tomas in 2013. Dr. Dorotan is a member of AAN and AES.

Dr. Dorotan is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.